News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,350 Results
Type
Article (39554)
Company Profile (247)
Press Release (656549)
Section
Business (204105)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81010)
Employer Resources (172)
FDA (16155)
Job Trends (14843)
News (345049)
Policy (32500)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (4)
Adcomms (20)
Allergies (80)
Alliances (49376)
ALS (83)
Alzheimer's disease (1356)
Antibody-drug conjugate (ADC) (109)
Approvals (16158)
Artificial intelligence (233)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (250)
Cancer (2013)
Cardiovascular disease (162)
Career advice (1673)
Career pathing (29)
CAR-T (140)
Cell therapy (397)
Cervical cancer (19)
Clinical research (65732)
Collaboration (769)
Compensation (466)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1981)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6336)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86222)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111702)
Executive appointments (649)
FDA (17274)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (690)
Gene editing (97)
Generative AI (18)
Gene therapy (278)
GLP-1 (685)
Government (4381)
Grass and pollen (4)
Guidances (49)
Healthcare (18809)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2713)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (311)
IPO (16486)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7901)
Liver cancer (70)
Lung cancer (293)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (268)
MASH (61)
Medical device (13326)
Medtech (13331)
Mergers & acquisitions (19407)
Metabolic disorders (632)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (1839)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2451)
Now hiring (37)
Obesity (340)
Opinion (201)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (137)
Partnered (20)
Patents (204)
Patient recruitment (96)
Peanut (46)
People (57102)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20471)
Phase II (28945)
Phase III (21574)
Pipeline (1056)
Podcasts (45)
Policy (113)
Postmarket research (2563)
Preclinical (8658)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5901)
Recruiting (65)
Regulatory (22149)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (121)
Series B (78)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2116)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (13)
Supply chain (60)
Tariffs (11)
The Weekly (27)
United States (21304)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (109)
Last 7 days (707)
Last 30 days (2682)
Last 365 days (33505)
2025 (8243)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32110)
2016 (31482)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37710)
Australia (6167)
California (5573)
Canada (1878)
China (476)
Colorado (247)
Connecticut (256)
Delaware (128)
Europe (80867)
Florida (827)
Georgia (196)
Idaho (57)
Illinois (500)
India (24)
Indiana (292)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (8)
Maine (61)
Maryland (832)
Massachusetts (4193)
Michigan (209)
Minnesota (371)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1590)
New Mexico (28)
New York (1602)
North Carolina (922)
North Dakota (7)
Northern California (2451)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1261)
Puerto Rico (9)
Rhode Island (27)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2116)
Tennessee (94)
Texas (831)
Utah (164)
Virginia (130)
Washington D.C. (57)
Washington State (515)
West Virginia (3)
Wisconsin (49)
696,350 Results for "hygieia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors
Hygieia is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.
May 2, 2023
·
3 min read
BioMidwest
UAT Group Subsidiary Launches New Hygieia Ageless Skin Care Line
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, LLC, is re-branding and expanding its highly lauded Hygieia Skin care product suite as “Hygieia Ageless”.
August 12, 2022
·
4 min read
BioMidwest
Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program
Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program.
December 13, 2022
·
3 min read
BioMidwest
Hygieia announces new CPT codes for autonomous insulin dose titration
Hygieia, a digital therapeutics company for insulin therapy, announces the American Medical Association (AMA) CPT Editorial Panel has approved two new Category III codes for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology.
July 26, 2022
·
3 min read
BioMidwest
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
Umbra Applied Technologies Group, Inc. announced that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel.
August 2, 2022
·
4 min read
Business
Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program
Hygieia adds Metro Detroit Endocrinology Center as clinical partner for its d-Nav® Insulin Management Program.
August 30, 2022
·
3 min read
Business
Diabetes Technology Leader and Global Business Executive Doug Lawrence Joins Hygieia as CEO
Hygieia, a digital therapeutics company for insulin therapy, has appointed Doug Lawrence its chief executive officer, responsible for leading operations, development, and global growth of the company and its d-Nav® Insulin Management Program.
August 23, 2022
·
4 min read
Business
Hygieia adds clinical partners in New York and North Carolina to its d-Nav® Insulin Management Program
Hygieia, a provider of digital therapeutics for insulin management, has added Endocrine Associates of West Village P.C. in Manhattan and Long Island City, NY, and Physicians East in Greenville, NC, as clinical partners.
September 12, 2022
·
4 min read
Biotech Beach
Hygieia Launches d-Nav® Clinical Partnership Program at AACE Annual Meeting
Hygieia, a digital therapeutics company, announced the official launch of its d-Nav Clinical Partnership Program for endocrinology practices treating patients with type 2 diabetes.
May 12, 2022
·
3 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
1 of 69,635
Next
